Hematology and thrombosis congresses in Bilbao

The LXVIII National Congress of the Spanish Society of Hematology and Hemotherapy (SEHH) and the XLII National Congress of the Spanish Society of Thrombosis and Hemostasis (SETH) convened at the Bilbao Exhibition Centre in Barakaldo. The event saw record attendance of approximately 2,400 professionals.

Discussions centered on therapeutic advances for blood cancers, the use of artificial intelligence, and the integration of immunotherapy and gene therapy into clinical practice. Experts addressed patient access to innovations like CAR-T cell therapies and bispecific antibodies. Additionally, medical leadership advocated for extending the specialty’s training program from four to five years to manage increasing field complexity.

During the congress, AbbVie presented research in oncohematology, specifically regarding chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and diffuse large B-cell lymphoma (DLBCL). Symposiums focused on individualizing care for elderly CLL patients and integrating scientific evidence with clinical experience in DLBCL management.